Finasteride
Product Images NDC 68071-1648

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 68071-1648). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 1648 9

NuCare Pharmaceuticals is a company that produces a medication called Finasteride 5mg in the form of 90 tablets. The medication is used for a specific purpose, but that information is not available in the provided text. The manufacturer's NDC (National Drug Code) for this product is 31722-525-50. The expiration date is not readable in the text. It is important to consult a doctor for medication advice and information on potential side effects. The text also includes a warning to keep the medication out of reach of children and store it at a controlled temperature of 68.77°F.*

FDA Label Image

Figure 1 Symptom Score In A Long-term Efficacy And Safety Study (Finasteride Fig1)

FDA Label Image

Figure 2 Percent Of Patients Having Surgery For Bph, Including Turp (Finasteride Fig2)

FDA Label Image

Figure 4 Prostate Volume In A Long-term Efficacy And Safety Study (Finasteride Fig3)

Mean Percent Change from Baseline + 1 SE in Prostate Volume in a Long-Term Efficacy and Safety Study. The study compares the baseline prostate volume with the prostate volume at Year 1, Year 2, Year 3, and Year 4 for two groups: Placebo and Finasteride. The numbers indicate the average change from baseline and 1 standard error (SE) for each year. The Placebo group had a baseline prostate volume of 155, which decreased to 85 at Year 4. The Finasteride group had a baseline prostate volume of 157, which decreased to 102 at Year 4.*

FDA Label Image

Figure 5 Cumulative Incidence Of A 4-point Rise In Aua Symptom Score By Treatment Group (Finasteride Fig4)

FDA Label Image

Chemical Structure (Finasteride Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.